Unsupervised subtyping and methylation landscape of pancreatic ductal adenocarcinoma

Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive form of pancreatic cancer that typically manifests itself at an advanced stage and does not respond to most treatment modalities. The survival rate of a PDAC patient is less than 5%, with a median survival of just a couple of months. A better...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Shikha, Singh, Amar Pratap, Gupta, Dinesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820567/
https://www.ncbi.nlm.nih.gov/pubmed/33521362
http://dx.doi.org/10.1016/j.heliyon.2021.e06000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820567/
https://www.ncbi.nlm.nih.gov/pubmed/33521362
http://dx.doi.org/10.1016/j.heliyon.2021.e06000

Ejemplares similares